Connect Biopharma Holdings Ltd (CNTB)

Nasdaq Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Financial Position (from SEC Filings)

$46.0M
Cash & Equivalents
$16.0M
Quarterly Burn Rate
9 mo
Est. Cash Runway
$151M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT06733480 Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue OTHER Recruiting 499

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for CNTB.

SEC EDGAR Filings

All SEC filings for Connect Biopharma Holdings Ltd on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.